MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$96,207,000
(-8.28%↓ Y/Y)
Interest income
$14,591,000
(9.80%↑ Y/Y)
Loss before income
taxes
-$95,626,000
(-7.94%↓ Y/Y)
Income tax expense
$581,000
(123.46%↑ Y/Y)
Total other income,
net
$14,498,000
(9.19%↑ Y/Y)
Other expense, net
-$93,000
(-745.45%↓ Y/Y)
Loss from operations
-$110,124,000
(-8.10%↓ Y/Y)
Total operating
expenses
$110,124,000
(8.10%↑ Y/Y)
Research and development
$77,889,000
(11.09%↑ Y/Y)
General and
administrative
$32,235,000
(1.50%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (TERN)